Adolescents with co-occurring substance use and mental conditions in a private managed care health plan: Prevalence, patient characteristics, and treatment initiation and engagement

American Journal on Addictions

Volumn 15, Issue SUPPL. 1, 2006, Pages s67-s79

  Chi, Felicia W ^a   Sterling, Stacy ^a   Weisner, Constance ^a,b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CHILD PSYCHIATRY; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; EMERGENCY CARE; FEMALE; HEALTH CARE PLANNING; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; MEDICAL SPECIALIST; MENTAL HEALTH; PREVALENCE; PRIMARY MEDICAL CARE; PRIVATE PRACTICE; SCHOOL CHILD; SEX DIFFERENCE; SUBSTANCE ABUSE; TREATMENT INDICATION;

EID: 33845876257     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490601006022     Document Type: Article

References (62)

1. Bukstein OG, Glancy LJ, Kaminer Y. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry. 1992;31:1041-1045.
2. Grilo CM, Becker DF, Walker ML, Levy KN, Edell WS, McGlashan TH. Psychiatric comorbidity in adolescent inpatients with substance use disorders. J Am Acad Child Adolesc Psychiatry. 1995;34:1085-1091.
3. Kandel DB, Johnson JG, Bird HR, et al. Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA Study. J Am Acad Child Adolesc Psychiatry. 1999;38:693-699.
4. Whitmore EA, Mikulich SK, Ehlers KM, Crowley TJ. One-year outcome of adolescent females referred for conduct disorder and substance abuse/dependence. Drug Alcohol Depend. 2000;59:131-141.
5. Riggs PD, Baker S, Mikulich SK, Young SE, Crowley TJ. Depression in substance-dependent delinquents. J Am Acad Child Adolesc Psychiatry. 1995;34:764-771.
6. Loeber R, Green SM, Lahey BB, Frick PJ, McBurnett K. Findings on disruptive behavior disorders from the first decade of the Developmental Trends Study. Clin Child Fam Psychol Rev. 2000;3:37-60.
7. White HR, Xie M, Thompson W, Loeber R, Stouthamer-Loeber M. Psychopathology as a predictor of adolescent drug use trajectories. Psychol Addict Behav. 2001;15:210-218.
8. Brown SA, Gleghorn A, Schuckit MA, Myers MG, Mott MA. Conduct disorder among adolescent alcohol and drug abusers. J Stud Alcohol. 1996;57:314-324.
9. Grella CE, Hser YI, Joshi V, Rounds-Bryant J. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J Nerv Ment Dis. 2001;189:384-392.
10. Kaminer Y. Addictive disorders in adolescents. Psychiatr Clin North Am. 1999;22:275-288.
11. Myers MG, Stewart DG, Brown SA. Progression from conduct disorder to antisocial personality disorder following treatment for adolescent substance abuse. Am J Psychiatry. 1998;155:479-485.
12. Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol. 1988;49:219-224.
13. Randall J, Henggeler SW, Pickrel SG, Brondino MJ. Psychiatric comorbidity and the 16-month trajectory of substance-abusing and substance-dependent juvenile offenders. J Am Acad Child Adolesc Psychiatry. 1999;38:1118-1124.
14. Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res. 1999;35 Suppl:S93-S100.
15. Babor TF, Dolinsky ZS, Meyer RE, Hesselbrock M, Hofmann M, Tennen H. Types of alcoholics: concurrent and predictive validity of some common classification schemes. Br J Addict. 1992;87:1415-1431.
16. Gonzalez G, Rosenheck RA. Outcomes and service use among homeless persons with serious mental illness and substance abuse. Psychiatr Serv. 2002;53:437-446.
17. Kaminer Y, Tarter RW, Bukstein OG, Kabene M. Comparison between treatment completers and noncompleters among dually diagnosed substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry. 1992;31:1046-1049.
18. Dobkin PL, Chabot L, Maliantovitch K, Craig W. Predictors of outcome in drug treatment of adolescent inpatients. Psychol Rep. 1998;83:175-786.
19. National Mental Health Association. What have states done to ensure health insurance parity? (on-line). 2006. Available at: http://www.nmha.org/ state/parity/state_parity.cfm. Accessed Jun 30, 2006.
20. Institute of Medicine. Improving the Quality of Health Care for Mental and Substance-Use Conditions: Quality Chasm Series. Washington, DC: National Academies Press; 2005.
21. Peck MC. State health care reform: mental health parity for children in California. Psychiatr Serv. 2001;52:743-745, 768.
22. U.S. Department of Health and Human Services. Mental Health: A Report of the Surgeon General-Executive Summary. Rockville, MD: Center for Mental Health Services, Substance Abuse and Mental Health Services Administration; 1999.
23. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occuring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996;66:17-31.
24. DeMilio L. Psychiatric syndromes in adolescent substance abusers. Am J Psychiatry. 1989;146:1212-1214.
25. Greenbaum PE, Prange ME, Friedman RM, Silver SE. Substance abuse prevalence and comordibity with other psychiatric disorders among adolescents with severe emotional disturbances. J Am Acad Child Adolesc Psychiatry. 1991;30:575-583.
26. Clark DB, Pollock N, Bukstein OG, Mezzich AC, Bromberger JT, Donovan JE. Gender and comorbid psychopathology in adolescents with alcohol dependence. J Am Acad Child Adolesc Psychiatry. 1997;36:1195-1203.
27. Hser Y-I, Grella CE, Hubbard RL, et al. An evaluation of drug treatments for adolescents in 4 US cities. Arch Gen Psychiatry. 2001;58:689-695.
28. Sterling S, Weisner C. Chemical dependency and psychiatric services for adolescents in private managed care: implications for outcomes. Alcohol Clin Exp Res. 2005;25:801-809.
29. Fehon DC, Becker DF, Grilo CM, et al. Diagnostic comorbidity in hospitalized adolescents with conduct disorder. Compr Psychiatry. 1997;38:141-145.
30. King RD, Gaines LS, Lambert EW, Summerfelt WT, Bickman L. The co-occurrence of psychiatric and substance use diagnoses in adolescents in different service systems: frequency, recognition, cost, and outcomes. J Behav Health Serv Res. 2000;27:417-430.
31. Kramer TL, Robbins JM, Phillips SD, Miller TL, Burns BJ. Detection and outcomes of substance use disorders in adolescents seeking mental health treatment. J Am Acad Child Adolesc Psychiatry. 2003;42:1318-1326.
32. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry. 1987;44:505-513.
33. Whitmore EA, Mikulich SK, Thompson LL, Riggs PD, Aarons GA, Crowley TJ. Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperactivity disorder, and gender. Drug Alcohol Depend. 1997;47:87-97.
34. Rowe CL, Liddle HA, Greenbaum PE, Henderson CE. Impact of psychiatric comorbidity on treatment of adolescent drug abusers. J Subst Abuse Treat. 2004;26:129-140.
35. Cornelius JR, Maisto SA, Martin CS, et al. Major depression associated with earlier alcohol relapse in treated teens with AUD. Addict Behav. 2004;29:1035-1038.
36. Horner BR, Scheibe KE. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Am Acad Child Adolesc Psychiatry. 1997;36:30-36.
37. Gilbert M, Fine S, Haley G. Factors associated with dropout from group psychotherapy with depressed adolescents. Can J Psychiatry. 1994;39:358-359.
38. Wise BK, Cuffe SP, Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. J Subst Abuse Treat. 2001;21:161-165.
39. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav. 1995;36:1-10.
40. Aday L, Andersen RM. A framework for the study of access to medical care. Health Serv Res. 1974;9:208-220.
41. Weisner C, Schmidt LA. Rethinking access to alcohol treatment. Recent Dev Alcohol. 2001;15:107-136.
42. Weisner C. Access to alcohol treatment in the 21st century. Old worries and new optimism. Overview. Recent Dev Alcohol. 2001;15:99-105.
43. Schmidt L, Weisner C. Public health perspectives on access and need for substance abuse treatment. In: Tucker JA, Donovan DM, Marlatt GA, eds. Changing Addictive Behavior: Bridging Clinical and Public Health Strategies. New York: Guildford Press;1999:67-96.
44. Booth BM, Staton M, Leukefeld C. Substance use health services research. Subst Use Misuse. 2001;36:673-685.
45. Grilo CM, Becker DF, Fehon DC, Edell WS, McGlashan TH. Conduct disorder, substance use disorders, and coexisting conduct and substance use disorders in adolescent inpatients. Am J Psychiatry. 1996;153:914-920.
46. Lewinsohn PM, Gotlib IH, Seeley JR. Adolescent psychopathology: IV. Specificity of psychosocial risk factors for depression and substance abuse in older adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34:1221-1229.
47. Blood L, Cornwall A. Pretreatment variables that predict completion of an adolescent substance abuse treatment program. J Nerv Ment Dis. 1994;182:14-19.
48. Brook JS, Richter L, Rubenstone E. Consequences of adolescent drug use on psychiatric disorders in early adulthood. Ann Med. 2000;32:401-407.
49. Clark DB. The natural history of adolescent alcohol use disorders. Addiction. 2004;99 Suppl 2:5-22.
50. Crowley TJ, Mikulich SK, Macdonald M, Young SE, Zerbe GO. Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcomes. Drug Alcohol Depend. 1998;49:225-237.
51. Substance Abuse and Mental Health Services Administration. Report to Congress on the Prevention and Treatment of Co-occurring Substance Abuse Disorders and Mental Disorders. Bethesda, MD: Department of Health and Human Services; 2002.
52. Edmunds M, Frank R, Hogan M, McCarty D, Robinson-Beale R, Weisner C, eds. Managing Managed Care: Quality Improvement in Behavioral Health. Washington, DC: National Academy Press; 1997.
53. Weisner C, McCarty D, Schmidt L. New directions in alcohol and drug treatment under managed care. Am J Manag Care. 1999;5:SP57-SP69.
54. Horgan CM, Merrick EL. Financing of substance abuse treatment services. Recent Dev Alcohol. 2001;15:229-252.
55. Weisner C, Conell C, Hunkeler E, et al. Drinking patterns and problems of the 'stably insured': a study of the membership of a health maintenance organization. J Stud Alcohol. 2000;61:121-129.
56. Sterling S, Hinman A, Kohn CS, Weisner C. Pathways to Substance Abuse Treatment for Adolescents: Implications for Policy. Summary of provider Interviews. Report to Robert Wood Johnson Foundation. Oakland, CA: Division of Research, Kaiser Permanente Northern California; 2002.
57. Alaja R, Seppa K, Sillanaukee P, et al. Physical and mental comorbidity of substance use disorders in psychiatric consultations. European Consultation-Liaison Workgroup. Alcohol Clin Exp Res. 1998;22:1820-1824.
58. Sterling S, Kohn CS, Lu Y, Weisner C. Pathways to substance abuse treatment for adolescents in an HMO. J Psychoactive Drugs. 2004;36:439-453.
59. Saluja G, Iachan R, Scheidt PC, Overpeck MD, Sun W, Giedd JN. Prevalence of and risk factors for depressive symptoms among young adolescents. Arch Pediatr Adolesc Med. 2004;158:760-765.
60. Lipschitz DS, Rasmusson AM, Anyan W, Cromwell P, Southwick SM. Clinical and functional correlates of posttraumatic stress disorder in urban adolescent girls at a primary care clinic. J Am Acad Child Adolesc Psychiatry. 2000;39:1104-1111.
61. Mertens JR, Lu YW, Parthasarathy S, Moore C, Weisner CM. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison to matched controls. Arch Intern Med. 2003;163:2511-2517.
62. Mertens JM, Weisner C, Ray GT, Fireman B, Walsh K. Hazardous drinkers and drug users in HMO primary care: prevalence, medical conditions, and costs. Alcohol Clin Exp Res. 2005;29:989-998.